Media Centre

Find out more about the latest news at Virtus Health, including medical breakthroughs in fertility treatment, growth within our network, and research papers.

Contact Us for comment on recent developments in the industry or interview requests.

Australian First: New genetic testing set to improve access and outcomes for IVF patients

In an Australian first, Virtus Health comprising Melbourne IVF, Queensland Fertility Group and IVFAustralia has introduced karyomapping, a new genetic test that will significantly improve access to treatment and the chance of a live birth for couples wishing to avoid the transmission of a serious genetic disorder to their children.

Patients who know they are carriers of a genetic disease, for example cystic fibrosis, can have their embryos tested using karyomapping and preimplantation genetic diagnosis (PGD).

Virtus Health Acquires IVF Sunshine Coast Clinic

Sydney, Australia – Virtus Health (“Virtus”, ASX: VRT) Australia’s largest IVF provider today announced it has acquired the remaining 80% share of IVF Sunshine Coast in Queensland, taking full ownership of the clinic.

Virtus Health Comments on Employers Offering Egg Freezing for Female Staff

Virtus Health, the leading provider of fertility treatment and egg freezing in Australia, described the news of Facebook and Apple offering female staff egg freezing to preserve their fertility as recognition by two of the world’s most innovative companies, that this technology has come of age and is a real option for fertility preservation.

Virtus Health Full Year Financial Results FY2014

Pro-forma net profit after tax (NPAT) grew 17.2% on the previous year to $32 million, from $27.3 million; pro-forma revenue rose 6.7% on the previous year to $199.9 million, from $187.3 million. Actual (or statutory) revenue from ordinary activities increased 7.9% to $201.2 million from $186.6 million while statutory net profit attributable to the owners of Virtus Health Limited tripled to $30.9million, from $10.1 million.

Virtus Health Expands into Asia

Sydney, Australia – Virtus Health (“Virtus”, ASX: VRT), Australia’s largest IVF provider, is pleased to announce it has commenced development of its first international, Virtus branded fertility centre, in Singapore.

Virtus Health has joined together with three leading Singaporean fertility specialists to establish the ‘Virtus Fertility Centre’ at the Scotts Medical Centre in Singapore's CBD.

Virtus Health Acquires A Majority Stake In Irish IVF Provider, SIMS IVF (Video Announcement Included)

Virtus Health (“Virtus”, ASX: VRT) is pleased to announce it has acquired a 70% interest in Ireland’s largest IVF provider, SIMS IVF for €15.49 million (cash free/debt free basis).

SIMS IVF is a pioneer in the delivery of IVF services in Ireland and undertakes approximately 25% of Ireland’s IVF services from its state-of-the-art facility in Dublin.

For the 12 months to 31 December 2013, SIMS IVF generated revenue and maintainable EBITDA of €12.44 million and €2.85 million respectively.

Solid first half results show continued growth in revenue and earnings

Solid first half results show continued growth in revenue and earnings

Read more »


Half Year financial results – investor conference call details

Virtus Health Limited (ASX: VRT) will release its financial results for the half year ended 31 December 2013 on Wednesday 26th February, 2014.
Investors are invited to join a conference call hosted by Sue Channon, Group CEO and Glenn Powers, CFO and Company Secretary of Virtus from 10.00am to 10.45am (AEDT) on Wednesday, 26th February 2014.
Download conference call dial in details »

Virtus Health excels at FSA 2013

Virtus Health has reinforced its commitment to investing in scientific leadership and world-class technology for its patients with its outstanding involvement at this year’s Fertility Society of Australia (FSA) conference, hosted in Sydney from 1-4 September.

World Breakthrough - First Pregnancy From Ovarian Tissue Grafted in the Anterior Abdominal Wall

Virtus Health's world leading fertility preservation team, led by Associate Professor Kate Stern, Head of Fertility Preservation at Melbourne IVF and the Royal Women’s Hospital announced the world’s first pregnancy from ovarian tissue grafted in the anterior abdominal wall of a Victorian woman.

The Melbourne woman, Vali, sought the tissue preservation treatment to help save her fertility after the loss of ovarian function through cancer treatment.

Prior to surgery to remove her second ovary at the age of 23, she requested the ovarian tissue be frozen.

Career Opportunities

Interested in joining our team? Read about our current opportunities for fertility specialists.
Find out more...

© Virtus Group 2014